Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Sports betting has spread rapidly across U.S. states in the past five years. But the odds for further expansion may be fading as state legislatures prepare to return to work in 2024.